Takeda Pharmaceuticals | Products, Recalls & Controversies
Takeda Pharmaceuticals saw rapid growth suddenly slowed by a $2.4 billion legal settlement over cancer side effects of diabetes drug Actos.| Drugwatch.com
Takeda Pharmaceuticals saw rapid growth suddenly slowed by a $2.4 billion legal settlement over cancer side effects of diabetes drug Actos.| Drugwatch.com
Takeda Pharmaceuticals agreed to settle thousands of pending Actos bladder cancer lawsuits for $2.37 billion.| Drugwatch.com
Type-2 diabetes medication Actos is linked to serious side effects such as congestive heart failure and bladder cancer.| Drugwatch.com
Eli Lilly and Company, the first to mass produce insulin, penicillin and the Salk polio vaccine, has also drawn scrutiny over some of its drugs.| Drugwatch.com
The U.S. Food & Drug Administration regulates drugs and medical devices. It also collects reports on adverse events from these products.| Drugwatch.com
